Renascience
4889.TPharmaceutical
Filed as Renascience, Inc (2022-06–2022-06)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Toshio Miyata | 21.07% |
| Heights Capital Management, Inc. | 6.65% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 1
| DCI Partners Co., Ltd. | 4.59% |
Ownership history · 14
| Holder | Ratio | Change |
|---|---|---|
| Heights Capital Management, Inc.2026-03-12 · amended | 6.65% | no change |
| Heights Capital Management, Inc.2026-03-12 · amended | 6.65% | no change |
| Heights Capital Management, Inc.2026-03-12 · amended | 6.65% | -1.82pp |
| Heights Capital Management, Inc.2026-03-12 · amended | 8.47% | no change |
| Heights Capital Management, Inc.2026-03-12 · amended | 8.47% | +1.86pp |
| Heights Capital Management, Inc.2026-03-12 · amended | 6.61% | new |
| Toshio Miyata2025-12-19 | 21.07% | -0.46pp |
| DCI Partners Co., Ltd.2025-06-16 | 4.59% | -1.17pp |
| DCI Partners Co., Ltd.2025-02-03 | 5.76% | -1.07pp |
| DCI Partners Co., Ltd.2025-01-22 | 6.83% | -1.90pp |
| DCI Partners Co., Ltd.2025-01-21 | 8.73% | new |
| Toshio Miyata2024-12-20 · amended | 21.53% | -1.44pp |
| Miyata Toshio2024-09-20 | 22.97% | no change |
| Toshio Miyata2024-09-20 | 22.97% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.